Stockscreener 앱 받기
11.34
3.16%
-0.37
전일 마감가:
$11.71
열려 있는:
$11.77
하루 거래량:
119.29K
Relative Volume:
0.77
시가총액:
$308.28M
수익:
$56.44M
순이익/손실:
$-32.60M
주가수익비율:
-9.206
EPS:
-1.2318
순현금흐름:
$-35.15M
1주 성능:
+0.89%
1개월 성능:
+11.50%
6개월 성능:
-2.49%
1년 성능:
+0.00%
1일 변동 폭
$11.18
$12.00
1주일 범위
$10.34
$12.00
52주 변동 폭
$8.50
$17.19
Carlsmed Inc Stock (CARL) Company Profile
명칭
Carlsmed Inc
전화
858-295-9290
주소
1800 ASTON AVENUE, CARLSBAD
Compare CARL vs VEEV, BTSG, TEM, HQY, HNGE
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CARL
Carlsmed Inc
|
11.34 | 282.18M | 56.44M | -32.60M | -35.15M | -1.2318 |
VEEV
Veeva Systems Inc
|
192.74 | 28.83B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
69.03 | 13.69B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
60.27 | 10.40B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
95.31 | 7.55B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
84.05 | 6.42B | 646.34M | -512.40M | 202.76M | -6.6871 |
Carlsmed Inc Stock (CARL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-18 | 개시 | BTIG Research | Buy |
| 2025-08-18 | 개시 | BofA Securities | Buy |
| 2025-08-18 | 개시 | Goldman | Buy |
| 2025-08-18 | 개시 | Piper Sandler | Overweight |
| 2025-08-18 | 개시 | Truist | Buy |
Carlsmed Inc 주식(CARL)의 최신 뉴스
Needham initiates Carlsmed stock with buy rating on implant differentiation - Investing.com
Needham initiates Carlsmed stock with buy rating on implant differentiation By Investing.com - Investing.com India
CARL Forecast — Price Target — Prediction for 2027 - TradingView
Carlsmed, Inc. Actuals & Estimates (NASDAQ:CARL) - TradingView
Carlsmed, Inc. Actuals & Estimates (DUS:I82) - TradingView
Price to sales forward of Carlsmed, Inc. – NASDAQ:CARL - TradingView
Enterprise value to revenue forward of Carlsmed, Inc. – NASDAQ:CARL - TradingView
CARL Q1 2026 Earnings: Narrower Loss Beats Estimates as Clinical Progress ContinuesPre-Announcement Alert - dars.gov.et
I82 Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to EBITDA forward of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Enterprise value to revenue forward of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Carlsmed, Inc. Actuals & Estimates (LSX:A41CM7) - TradingView
A41CM7 Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Price to book forward of Carlsmed, Inc. – NASDAQ:CARL - TradingView
Price to sales forward of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Carlsmed Inc. (CARL) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
BTIG Maintains Carlsmed(CARL.US) With Buy Rating, Maintains Target Price $23 - Moomoo
Form 4 Carlsmed Inc For: 22 June By Investing.com - Investing.com Nigeria
Carlsmed Ord Shs (CARL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CARL: AI-driven personalized surgery platform accelerates growth and efficiency, outpacing traditional models - TradingView
CARLSMED INC (CARL) Stock Chart - ChartMill
Wall Street analysts think Carlsmed, Inc. (CARL) could surge 90.77%: Read this before placing a bet - MSN
CARL Q1 2026 Earnings: Narrower-than-Expected Loss as Development Progress ContinuesPeak Earnings Alert - newsline.com
Carlsmed Shareholders Back Directors and Auditor at Meeting - TipRanks
Carlsmed Stock Faces A Crucial Week After Friday’s Drop - Bez Kabli
Carlsmed, Inc. Cash Flow – LSX:A41CM7 - TradingView
CARL Q1 2026 Earnings: Personal Surgery Specialist Beats EPS Estimates; Stock RisesEarnings Surprise Score - The Legal Advocate
CARLCarlsmed Inc Stock Price and Quote - Finviz
Wall Street analysts see a 51.94% upside in Carlsmed, Inc. (CARL): Can the stock really move this high? - MSN
Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High? - sharewise.com
Basic earnings per share (basic EPS) of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Carlsmed (CARL) Stock: Jumps +3.57%, Approaching $11.89 2026-05-19Free Signal Network - Newser
Carlsmed (CARL) Down -1.66% — How Low Could It Go? 2026-05-14Earnings Breakout - newser.com
Price to cash flow ratio of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Return on equity % of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Total equity of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Carlsmed, Inc. Income Statement – LSX:A41CM7 - TradingView
Carlsmed raises FY 2026 revenue outlook to $72M-$77M as CMS proposes new MS-DRGs for Aprevo lumbar - MSN
Top Carlsmed (CARL) Competitors 2026 - MarketBeat
Number of shareholders of Carlsmed, Inc. – NASDAQ:CARL - TradingView
Carlsmed, Inc. Dividends – LS:A41CM7 - TradingView
Number of employees of Carlsmed, Inc. – LS:A41CM7 - TradingView
Operating expenses (excl. COGS) of Carlsmed, Inc. – LS:A41CM7 - TradingView
Enterprise value to EBITDA ratio of Carlsmed, Inc. – LS:A41CM7 - TradingView
Total debt per share of Carlsmed, Inc. – LS:A41CM7 - TradingView
Price to cash flow ratio of Carlsmed, Inc. – LS:A41CM7 - TradingView
Total equity of Carlsmed, Inc. – LS:A41CM7 - TradingView
Total liabilities of Carlsmed, Inc. – LS:A41CM7 - TradingView
EBIT per share of Carlsmed, Inc. – LS:A41CM7 - TradingView
Carlsmed Inc (CARL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Carlsmed Inc 주식 (CARL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Cordonnier Michael | CEO, President |
Mar 02 '26 |
Option Exercise |
0.34 |
197,855 |
66,281 |
1,554,501 |
| Cordonnier Michael | CEO, President |
Mar 02 '26 |
Sale |
13.29 |
197,855 |
2,629,889 |
1,356,646 |
1.79%
0.10%
자본화:
|
볼륨(24시간):